trending Market Intelligence /marketintelligence/en/news-insights/trending/eloum1r8nfdvkmy5g7ad6g2 content esgSubNav
In This List

Audentes Therapeutics names president/COO

Blog

Gauging Supply Chain Risk In Volatile Times

Blog

Insight Weekly: Banks' efficiency push; vacuuming carbon; Big Pharma diversity goals

Blog

The Future of Risk Management Digitization in Credit Risk Management

Blog

Climate Credit Analytics: Diving into the model


Audentes Therapeutics names president/COO

Audentes Therapeutics Inc. promoted Natalie Holles to president and COO.

Holles was senior vice president and COO.

In the new role, she will oversee the day-to-day operations of the company, including research, development, manufacturing, program management and corporate development.

Holles joined Audentes in 2015, bringing 15 years of corporate development, strategic planning and commercial experience gained in a range of therapeutic areas and with a focus on rare diseases, Audentes said in a statement.